Estimating the predictive validity of diabetic animal models in rosiglitazone studies

Obesity Reviews

Volumn 16, Issue 6, 2015, Pages 498-507

  Varga, O E ^a,b   Zsiros N ^c   Olsson, I A S ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Animal models; Human relevance; Predictive validity; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; ROSIGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASE STUDY; DIABETOGENESIS; DIET; DRUG EFFICACY; EXPERIMENTAL DIABETES MELLITUS; FACTORIAL ANALYSIS; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; NONHUMAN; PREDICTIVE VALIDITY; RODENT MODEL; SEX; STATISTICAL ANALYSIS; ANALYSIS; ANIMAL; ANIMAL FOOD; BLOOD; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; MALE; SEXUAL DEVELOPMENT; SPECIES DIFFERENCE;

ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; SEX CHARACTERISTICS; SPECIES SPECIFICITY; THIAZOLIDINEDIONES;

EID: 84929133059     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12278     Document Type: Article

References (33)

1. Graham MLBM, Papas KK, Hering BJ, Schuurman H-J. Species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation. Xenotransplantation 2011; 18: 328-342.
2. Whiteside GT, Adedoyin A, Leventhal L. Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans. Neuropharmacology 2008; 54: 767-775.
3. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). (2005). Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. [WWW document]. URL http://www.fda.gov/downloads/Drugs/Guidances/UCM078932.pdf (accessed January 30, 2015).
4. World Health Organization HSI/ESD/ICTRP. (2004). International Clinical Trials Registry Platform (ICTRP). [WWW document]. URL http://www.who.int/ictrp/en/ (accessed January 30, 2015).
5. Walton MK. Addressing and advancing the problem of missing data. J Biopharm Stat 2009; 19: 945-956.
6. Ghersi D, Clarke M, Berlin J etal. Reporting the findings of clinical trials: a discussion paper. Bull World Health Organ 2008; 86: 492-493.
7. Vedula SS, Li T, Dickersin K. Differences in reporting of analyses in internal company documents versus published trial reports: comparisons in industry-sponsored trials in off-label uses of gabapentin. PLoS Med 2013; 10: e1001378.
8. Janssen H, Speare S, Spratt NJ etal. Exploring the efficacy of constraint in animal models of stroke: meta-analysis and systematic review of the current evidence. Neurorehabil Neural Repair 2013; 27: 3-12.
9. van der Worp HB, Howells DW, Sena ES etal. Can animal models of disease reliably inform human studies? PLoS Med 2010; 7: e1000245.
10. Percie du Sert N, Rudd JA, Apfel CC, Andrews PL. Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT(3) receptor antagonists. Cancer Chemother Pharmacol 2011; 67: 667-686.
11. Lashev L, Pashov D, Kanelov I. Species specific pharmacokinetics of rolitetracycline. Zentralbl Veterinarmed A 1995; 42: 201-208.
12. Khan HA. CalcDose: a software for drug dosage conversion using metabolically active mass of animals. Drug Chem Toxicol 2003; 26: 51-58.
13. King AJ. The use of animal models in diabetes research. Br J Pharmacol 2012; 166: 877-894.
14. Rohatgi A (2012). WebPlotDigitizer. [WWW document]. URL http://www.arohatgi.info/WebPlotDigitizer/app/ (accessed January 30, 2015).
15. de Vries RB, Hooijmans CR, Tillema A, Leenaars M, Ritskes-Hoitinga M. A search filter for increasing the retrieval of animal studies in Embase. Lab Anim 2011; 45: 268-270.
16. Rahman S, Ismail AA, Ismail SB, Naing NN, Abdul Rahman AR. Effect of rosiglitazone/ramipril on preclinical vasculopathy in newly diagnosed, untreated diabetes and IGT patients: 1-year randomised, double-blind, placebo-controlled study. Eur J Clin Pharmacol 2007; 63: 733-741.
17. Louisa M, Takeuchi M, Takeuchi M, Nafrialdi A, Setiabudy R. A meta-analysis on treatment effects of thiazolidinediones for type 2 diabetes mellitus in Asian populations. Acta Med Indones 2011; 43: 39-52.
18. GSK.(2014). Studies filtered by compound rosiglitazone. [WWW document]. URL http://www.gsk-clinicalstudyregister.com/compounds/rosiglitazone#rs (accessed January 30, 2015).
19. Islam MS, Loots du T. Experimental rodent models of type 2 diabetes: a review. Methods Find Exp Clin Pharmacol 2009; 31: 249-261.
20. Turner PV, Brabb T, Pekow C, Vasbinder MA. Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci 2011; 50: 600-613.
21. Ricci MR, Ulman EA. Laboratory animal diets: a critical part of your in vivo research. Anim Lab News 2005; 4: 1-6.
22. Choi JW, Aseer KR, Chaudhari HN, Mukherjee R, Choi M, Yun JW. Gender dimorphism in regulation of plasma proteins in streptozotocin-induced diabetic rats. Proteomics 2013; 13: 2482-2494.
23. McKinney WT Jr, Bunney WE Jr. Animal model of depression. I. Review of evidence: implications for research. Arch Gen Psychiatry 1969; 21: 240-248.
24. McMurray F, Cox RD. Mouse models and type 2 diabetes: translational opportunities. Mamm Genome 2011; 22: 390-400.
25. Harwood HJ Jr, Listrani P, Wagner JD. Nonhuman primates and other animal models in diabetes research. J Diabetes Sci Technol 2012; 6: 503-514.
26. Ionut V, Liu H, Mooradian V etal. Novel canine models of obese prediabetes and mild type 2 diabetes. Am J Physiol Endocrinol Metab 2010; 298: E38-E48.
27. Lee MS, Song KD, Yang HJ, Solis CD, Kim SH, Lee WK. Development of a type II diabetic mellitus animal model using Micropig(R). Lab Anim Res 2012; 28: 205-208.
28. Yu S, Zheng L, Li Y etal. A cross-species analysis method to analyze animal models' similarity to human's disease state. BMC Syst Biol 2012; 6(Suppl. 3): S18.
29. Breyer MD. Drug discovery for diabetic nephropathy: trying the leap from mouse to man. Semin Nephrol 2012; 32: 445-451.
30. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). (2008). Guidance for industry diabetes mellitus: developing drugs and therapeutic biologics for treatment and prevention. [WWW document]. URL http://www.fda.gov/downloads/Drugs/Guidances/ucm071624.pdf (accessed January 30, 2015).
31. Lenters-Westra E, Schindhelm RK, Bilo HJ, Slingerland RJ. Haemoglobin A1c: Historical overview and current concepts. Diabetes Res Clin Pract 2013; 99: 75-84.
32. De Tata V, Novelli M, Bombara M etal. Determination of glycated hemoglobins in the rat: comparison between two different chromatographic methods and application in experimental diabetology. Res Exp Med (Berl) 1996; 196: 9-16.
33. Dan K, Fujita H, Seto Y, Kato R. Relation between stable glycated hemoglobin A1C and plasma glucose levels in diabetes-model mice. Exp Anim 1997; 46: 135-140.